Plunkett Research Online: AstraZeneca plc

ASTRAZENECA PLC (AZN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from intern.....



AstraZeneca plc
Ticker: AZN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 44 2037495000
Fax: 44 1223352858
Address: 1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge, CB2 0AA United Kingdom

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Diversified
Pharmaceutical Research & Development
Contacts Description
Pascal Soriot CEO/Director
Aradhana Sarin CFO/Director
See More
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from intern.....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Atacand
Crestor
Lokelma
Arimidex
Faslodex
Accolate
Bricanyl
Symbicort pMDI
Name Title Salary (GBP) Bonus (GBP)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: